BOUNDLESS BIO, INC. Cash and Restricted Cash
BOUNDLESS BIO, INC. (BOLD) had Cash and Restricted Cash of $20.21 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.21M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.04M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.43M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.54M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $20.21M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $18.04M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $18.43M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $15.54M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $15.26M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $15.68M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $27.15M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $40.77M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $31.92M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $25.70M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $24.27M 10-K · filed 2026-03-09 |
| 2023-09-30 | $21.52M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $41.88M 10-Q · filed 2024-08-12 |
| 2023-03-31 | $21.59M 10-Q · filed 2024-05-13 |
| 2022-12-31 | $11.48M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |